| For: | Chen K, Feng X, Shi Y, Li XL, Shi ZR, Lan X. Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature. World J Gastrointest Oncol 2025; 17(1): 98433 [PMID: 39817135 DOI: 10.4251/wjgo.v17.i1.98433] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i1/98433.htm |
| Number | Citing Articles |
| 1 |
Zeshan Chen, Xin Deng, Yuanhong Lu, Ling Lu, Yijue Qin, Haishun Qu, Shaohang Lan. Role of miRNA‑214‑3p in cancer (Review). Oncology Reports 2025; 54(4) doi: 10.3892/or.2025.8957
|
| 2 |
Zhitao Chen, Yuhao Wu, Chenchen Ding, Yangjun Gu, Weilin Wu, Qiyong Li. Long-term survival after targeted therapy plus immunotherapy without chemotherapy in advanced gallbladder carcinoma: a case report and literature review. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1629985
|
| 3 |
Ken Hatano, Yusuke Okamura, Kai Nakao, Gensho Tanke, Gen Yamamoto, Kenji Uryuhara, Masato Narita, Shigeo Hara, Satoshi Kaihara. Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report. Surgical Case Reports 2026; 12(1) doi: 10.70352/scrj.cr.26-0221
|
| 4 |
Tao Li, Zhiqin Li, Keren Li, Gong Li, Guangxin Li, Ying Zhao. Neoadjuvant radiotherapy combined with targeted and immune therapies achieves a pathological complete response in borderline resectable gallbladder cancer: a case report and literature review. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1574329
|